1. Home
  2. /
  3. Availability
  4. /
  5. The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug resistant tuberculosis in India and China

The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug resistant tuberculosis in India and China

Description

We investigated the epidemiologic impact, cost-effectiveness, and budget impact of hypothetical novel prophylactic prevention of disease TB vaccines on RR/MDR-TB in China and India.
TB vaccine theme
Availability
Economic impact/cost-effectiveness, Epidemiological impact

Project details

Country
China, India
Timeline
2021
Target group
Adolescents, Adults, People with AMR-TB
Vaccine
Hypothetical vaccines
Type of protection of vaccine
Prevention of disease, Prevention of infection
Type of research
Modelling
Partners involved
Aeras, BMGF, Chinese CDC, IAVI, LSHTM, National TB elimination programme India, Sanofi Pasteur, UK MRC, WHO
Type of project
research
Funder
Civil Society
Governmental Body

Resources

The epidemiologic impact and cost-effectiveness of new tuberculosis vaccines on multidrug resistant tuberculosis in India and China

Contact

Joeri Buis
joeri.buis@kncvtbc.org
Click to copy link of this header Menu